STVNStevanato Group S.p.A.

$22.42

Price

$22.42-7.0%1Y
1M+15%1Y-7.0%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
7/10
Value62
Quality71
Momentum37
Growth49
Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a leading global provider of drug containment, drug delivery and diagnostic solutions as well as engineering solutions to the pharmaceutical, biotechnology and life sciences industries. We deliver an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug product life cycle from development to clinical and commercial stages. Our core capabilities in scientific research and development, our commitment to technical innovation and our engineering excellence are central to our ability to offer value-added solutions to our clients.

In the company’s own words · 20-F filed Mar 4, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$4.79B
1Y Return-7.0%
5Y Return+16%

For the full year FY2025, revenue was €1.19B (+7.4% year on year) and net income €140M.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.